Treatment-naive status and thyroid autoimmunity as determinants of early biochemical thyroid outcome after radioiodine therapy for Graves’ disease: A retrospective cohort study
Science Progress · 2026-10 · 109 (4)
DOI: 10.1177/00368504261504136 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Science Progress, online erschienen am 05.11.2026. Verfasst von Shihan Zhang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Graves Disease, Iodine Radioisotopes, Thyroid Gland, Autoimmunity. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The National Key R&D Program of China, The Beijing Hospitals Authority’s Ascent Plan, The “Qingmiao” Plan Program of Beijing Municipal Hospital Administration.
Abstract (Originalsprache)
Objective
Early biochemical thyroid outcomes after iodine-131 ( 131 I) therapy for Graves’ disease are heterogeneous. We aimed to identify baseline determinants of 3-month biochemical outcome and assess whether the FT3/FT4 ratio, thyrotroph thyroxine resistance index (TT4RI), or machine-learning algorithms added predictive value.
Methods
We retrospectively reviewed 637 consecutive patients with clinically documented Graves’ disease treated with 131 I between November 2022 and November 2024. Graves’ disease was identified from contemporaneous endocrinologist-recorded diagnoses rather than uniform thyrotropin-receptor antibody confirmation. Three-month thyroid status was classified as persistent overt hyperthyroidism, euthyroidism, or hypothyroidism using institutional biochemical reference ranges; remission was defined as euthyroidism or hypothyroidism. A prespecified multivariable logistic model included age, sex, treatment-naive status, disease duration, goiter grade, administered dose, 24-hour radioactive iodine uptake, thyroid peroxidase antibody (TPOAb), and thyroglobulin antibody. Cross-validated prediction models assessed derived indices and machine-learning algorithms.
Results
At 3 months, 464 patients (72.8%) achieved remission and 369 (57.9%) were hypothyroid. Treatment-naive status and higher TPOAb were independently associated with remission (OR 1.67, 95% CI 1.06–2.62; TPOAb OR 1.11 per log-unit, 1.01–1.23) and hypothyroidism (OR 1.95, 1.29–2.97; TPOAb OR 1.16, 1.06–1.27). Lower goiter grade and higher administered dose were also associated with both outcomes. Discrimination was modest (remission AUC 0.59; hypothyroidism AUC 0.62). Derived indices and machine-learning algorithms did not consistently improve clinically meaningful prediction; an isolated positive continuous NRI for hypothyroidism was not supported by improved AUC or IDI. By 6 months, 273 patients, all hypothyroid at 3 months, had not returned; among reassessed 3-month hypothyroid patients, 21% reverted to euthyroidism.
Conclusions
Treatment-naive status and TPOAb were associated with early biochemical outcome after 131 I therapy, but baseline prediction remained limited. Early hypothyroidism should be interpreted as a 3-month biochemical state rather than definitive ablation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Shihan Zhang
Förderung
- The National Key R&D Program of China
- The Beijing Hospitals Authority’s Ascent Plan
- The “Qingmiao” Plan Program of Beijing Municipal Hospital Administration
Zitieren
APA
Zhang, S., Ding, X., Liu, J., & Wang, G. (2026). Treatment-naive status and thyroid autoimmunity as determinants of early biochemical thyroid outcome after radioiodine therapy for Graves’ disease: A retrospective cohort study. Science Progress, 109(4). https://doi.org/10.1177/00368504261504136
Vancouver
Zhang S, Ding X, Liu J, Wang G. Treatment-naive status and thyroid autoimmunity as determinants of early biochemical thyroid outcome after radioiodine therapy for Graves’ disease: A retrospective cohort study. Science Progress. 2026;109(4). doi:10.1177/00368504261504136
BibTeX
@article{Zhang2026,
author = {Zhang, Shihan and Ding, Xiaoyu and Liu, Jia and Wang, Guang},
title = {Treatment-naive status and thyroid autoimmunity as determinants of early biochemical thyroid outcome after radioiodine therapy for Graves’ disease: A retrospective cohort study},
journal = {Science Progress},
year = {2026},
volume = {109},
number = {4},
doi = {10.1177/00368504261504136}
}
EUVIMED